Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 4, 2005, Pages 1096-1106

  Milano, Michael T ^a   Vokes, Everett E ^a,b,c   Salama, Joseph K ^a   Stenson, Kerstin M ^a   Kao, Johnny ^a   Witt, Mary Ellyn ^a   Mittal, Bharat B ^d   Argiris, Athanassios ^e   Weichselbaum, Ralph R ^a   Haraf, Daniel J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c University of Chicago   (United States)

^d Departments of Radiation and Cellular Oncology   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemotherapy; Fluorouracil; Gemcitabine; Head and neck cancer; Paclitaxel; Reirradiation

Indexed keywords

CHEMOTHERAPY; DISEASE CONTROL; DOSIMETRY; PATIENT TREATMENT; RADIOTHERAPY; STATISTICAL METHODS; TOXICITY;

CHEMORADIOTHERAPY; HEAD-AND-NECK CANCER; LOCOREGIONAL CONTROL RATE; MULTIVARIATE ANALYSIS;

TUMORS;

FLUOROURACIL; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DERMATITIS; DYSPHAGIA; EROSION; FEMALE; FOLLOW UP; HEAD CANCER; HUMAN; MALE; MOUTH DISEASE; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; NECK CANCER; NEUROPATHY; NEUTROPENIA; PALATE DISEASE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SECOND CANCER; SOFT TISSUE DISEASE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TISSUE NECROSIS; TOXICITY; TREATMENT OUTCOME; TRISMUS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PACLITAXEL; RADIOTHERAPY DOSAGE;

EID: 20044383937     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.08.029     Document Type: Article

References (45)

1. M.T. Milano, S.J. Chmura, D.J. Haraf Treatment of locally recurrent and second primary head and neck cancers In: UpToDate. vol 11.3 2004 UpToDate Wellesley, MA
2. J. Kao, M.C. Garofalo, M.T. Milano Reirradiation of recurrent and second primary head and neck malignancies: A comprehensive review Cancer Treat Rev 29 2003 21 30
3. D. Haraf, T. Chung, K. Stenson High dose reirradiation with concomitant chemotherapy for local/regionally recurrent head and neck cancer (HNC): Results in 48 patients Proc Am Soc Clin Oncol 19 2000 413a
4. R.G. Williams Recurrent head and neck cancer: The results of treatment Br J Surg 61 1974 691 697
5. J.A. Ridge Squamous cancer of the head and neck: Surgical treatment of local and regional recurrence Semin Oncol 20 1993 419 429
6. J.T. Parsons, W.M. Mendenhall, S.P. Stringer Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx Int J Radiat Oncol Biol Phys 32 1995 605 609
7. M.P. McLaughlin, J.T. Parsons, D.A. Fein Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx Head Neck 18 1996 229 235
8. Liverpool Head and Neck Oncology Group A phase III randomised trial of cisplatinum, methotrexate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck Br J Cancer 61 1990 311 315
9. A.A. Forastiere, B. Metch, D.E. Schuller Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study J Clin Oncol 10 1992 1245 1251
10. C. Jacobs, F. Meyers, C. Hendrickson A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck: A Northern California Oncology Group study Cancer 52 1983 1563 1569
11. C. Jacobs, G. Lyman, E. Velez-Garcia A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck J Clin Oncol 10 1992 257 263
12. A. Forastiere, T. Leong, B. B Murphy A phase III trial of high-dose paclitaxel + cisplatin + G-CSF versus low-dose paclitaxel + cisplatin in patients with advanced squamous cell carcinoma of the head and neck (HNSCC): An Eastern Cooperative Oncology Group trial [Abstract] Proc Am Soc Clin Oncol 15 1997 617a
13. B. Murphy, Y. Li, D. Cella Phase III study comparing cisplatin (C) & 5-fluorouracil (F) versus cisplatin & paclitaxel (T) in metastatic/recurrent head & neck cancer (MHNC) [Abstract] Proc Am Soc Clin Oncol 20 2001 894a
14. A. Forastiere, W. Koch, A. Trotti Head and neck cancer N Engl J Med 345 2001 1890 1900
15. A. Argiris, Y. Li, B.A. Murphy Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy J Clin Oncol 22 2004 262 268
16. B. Emami, M. Bignardi, G.J. Spector Reirradiation of recurrent head and neck cancers Laryngoscope 97 1987 85 88
17. C.C. Wang Re-irradiation of recurrent nasopharyngeal carcinoma--Treatment techniques and results Int J Radiat Oncol Biol Phys 13 1987 953 956
18. M. Benchalal, J.M. Bachaud, P. Francois Hyperfractionation in the reirradiation of head and neck cancers: Result of a pilot study Radiother Oncol 36 1995 203 210
19. K.R. Stevens Jr, A. Britsch, W.T. Moss High-dose reirradiation of head and neck cancer with curative intent Int J Radiat Oncol Biol Phys 29 1994 687 698
20. A.W. Lee, W. Foo, S.C. Law Reirradiation for recurrent nasopharyngeal carcinoma: Factors affecting the therapeutic ratio and ways for improvement Int J Radiat Oncol Biol Phys 38 1997 43 52
21. P.M. Teo, W.H. Kwan, A.T. Chan How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 40 1998 897 913
22. L.A. Dawson, L.L. Myers, C.R. Bradford Conformal re-irradiation of recurrent and new primary head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 377 385
23. D.J. Haraf, E.E. Vokes, W.R. Panje Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer Am J Clin Oncol 14 1991 419 426
24. D.J. Haraf, E.E. Vokes, R.R. Weichselbaum Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer Laryngoscope 102 1992 630 636
25. E.E. Vokes, W.R. Panje, R.L. Schilsky Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: A phase I-II study J Clin Oncol 7 1989 761 768
26. D.J. Haraf, R.R. Weichselbaum, E.E. Vokes Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease Ann Oncol 7 1996 913 918
27. D. Gandia, P. Wibault, T. Guillot Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer Head Neck 15 1993 8 15
28. B. Weppelmann, R.H. Wheeler, G.E. Peters Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation Int J Radiat Oncol Biol Phys 22 1992 1051 1056
29. R. De Crevoisier, J. Bourhis, C. Domenge Full-dose reirradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients J Clin Oncol 16 1998 3556 3562
30. S.A. Spencer, J. Harris, R.H. Wheeler RTOG 96-10: Reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck Int J Radiat Oncol Biol Phys 51 2001 1299 1304
31. R. De Crevoisier, C. Domenge, P. Wibault Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma Cancer 91 2001 2071 2076
32. E.E. Vokes, D.J. Haraf, R. Mick Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer J Clin Oncol 12 1994 2351 2359
33. E.E. Vokes, M.S. Kies, D.J. Haraf Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer J Clin Oncol 18 2000 1652 1661
34. B. Brockstein, D.J. Haraf, K. Stenson Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck J Clin Oncol 16 1998 735 744
35. B. Brockstein, D.J. Haraf, K. Stenson A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer Ann Oncol 11 2000 721 728
36. Chmura SJ, Vokes EE, Garofalo M, et al. Long-term outcome of re-irradiation with concomitant chemotherapy for locally recurrent squamous cell carcinoma of the head and neck [Abstract]. Int J Radiat Oncol Biol Phys 2003;57 (Suppl.):S409-S410.
37. M. Machtay, D.I. Rosenthal, A.A. Chalian Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer Int J Radiat Oncol Biol Phys 59 2004 72 77
38. Milano M, Haraf D, Stenson K, et al. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine and twice-daily radiation in patients with poor-prognosis cancer of the head and neck. Clin Can Res 2004;10:4922-4932.
39. S.A. Spencer, R.H. Wheeler, G.E. Peters Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck Am J Clin Oncol 22 1999 1 5
40. U. Schaefer, O. Micke, P. Schueller Recurrent head and neck cancer: Retreatment of previously irradiated areas with combined chemotherapy and radiation therapy--Results of a prospective study Radiology 216 2000 371 376
41. S Spencer, R. Wheeler, G. Peters Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer Head Neck 25 2003 118 122
42. Damsker J, Langer CJ, Cheng T, et al. Safety and outcome of concurrent hyperfractionated split course radiotherapy with daily cisplatin and paclitaxel in patients with recurrent, unresectable, previously irradiated head and neck cancer [Abstract]. Proc Am Soc Clin Oncol 2003;22:499.
43. K.K. Ang, G.L. Jiang, Y. Feng Extent and kinetics of recovery of occult spinal cord injury Int J Radiat Oncol Biol Phys 50 2001 1013 1020
44. MT Milano, E.E. Vokes, M.E. Witt Retrospective comparison of intensity modulated radiation therapy (IMRT) and conventional three-dimensional RT (3DCRT) in advanced head and neck patients treated with definitive chemoradiation [Abstract] Proc Am Soc Clin Oncol 22 2003 499
45. D. Langlois, F. Eschwege, A. Kramar Reirradiation of head and neck cancers: Presentation of 35 cases treated at the Gustave Roussy Institute Radiother Oncol 3 1985 27 33